DermTech Beheer
Beheer criteriumcontroles 2/4
DermTech's CEO is Bret Christensen, appointed in May 2023, has a tenure of 1.5 years. total yearly compensation is $1.93M, comprised of 20.2% salary and 79.8% bonuses, including company stock and options. directly owns 0.007% of the company’s shares, worth $0.25. The average tenure of the management team and the board of directors is 2.9 years and 3.1 years respectively.
Belangrijke informatie
Bret Christensen
Algemeen directeur
US$1.9m
Totale compensatie
Percentage CEO-salaris | 20.2% |
Dienstverband CEO | 1.5yrs |
Eigendom CEO | 0.007% |
Management gemiddelde ambtstermijn | 2.9yrs |
Gemiddelde ambtstermijn bestuur | 3.1yrs |
Recente managementupdates
Recent updates
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%
May 21We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate
Mar 02Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%
Mar 02Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price
Dec 28Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky
Sep 18Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?
Jun 14Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023
May 10DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%
May 06We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jan 16Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)
Nov 08Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?
Oct 11DermTech grants stock options
Oct 11Diving Into DermTech
Sep 01Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80
Aug 10DermTech: Approaching An All Or Nothing Moment
Jun 13We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jun 04DermTech - Taking A Second Look At The Growth Thesis
Mar 31DermTech: Adoption Headwinds And Earnings Misses
Dec 23Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth
Dec 02Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$90m |
Dec 31 2023 | US$2m | US$389k | -US$101m |
Compensatie versus markt: Bret's total compensation ($USD1.93M) is above average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: Insufficient data to compare Bret's compensation with company performance.
CEO
Bret Christensen (53 yo)
1.5yrs
Tenure
US$1,928,967
Compensatie
Mr. Bret Christensen serves as Chief Executive Officer, President and Director at DermTech, Inc. since May 08, 2023. He serves as Director of Axena Health, Inc. Mr. Christensen had been Chief Commercial Of...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 1.5yrs | US$1.93m | 0.0071% $ 0.2 | |
CFO, Treasurer & Secretary | 5.2yrs | US$934.85k | 0.57% $ 19.9 | |
General Counsel | 3.8yrs | US$818.76k | 0.19% $ 6.7 | |
Senior Director of Investor Relations | no data | geen gegevens | geen gegevens | |
Chief Compliance Officer | 2.3yrs | geen gegevens | geen gegevens | |
Chief Medical Officer | 3.4yrs | geen gegevens | geen gegevens | |
Chief Commercial Officer | 1.2yrs | geen gegevens | geen gegevens |
2.9yrs
Gemiddelde duur
52yo
Gemiddelde leeftijd
Ervaren management: DMTK.Q's management team is considered experienced (2.9 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 1.5yrs | US$1.93m | 0.0071% $ 0.2 | |
Independent Director | 5.3yrs | US$149.64k | 0.28% $ 9.9 | |
Independent Director | 2.3yrs | US$136.64k | 0.094% $ 3.3 | |
Independent Chairman of the Board | 8.3yrs | US$188.64k | 0.35% $ 12.2 | |
Independent Director | 2.3yrs | US$139.64k | 0.081% $ 2.9 | |
Independent Director | 5.3yrs | US$156.64k | 0.20% $ 6.9 | |
Independent Director | 3.1yrs | US$134.64k | 0.092% $ 3.2 |
3.1yrs
Gemiddelde duur
57yo
Gemiddelde leeftijd
Ervaren bestuur: DMTK.Q's board of directors are considered experienced (3.1 years average tenure).